Thorsell Annika, Johnson Justin, Heilig Markus
Laboratory of Clinical and Translational Studies, NIAAA, NIH, Bethesda, Maryland 20892-1108, USA.
Alcohol Clin Exp Res. 2007 Aug;31(8):1302-7. doi: 10.1111/j.1530-0277.2007.00425.x. Epub 2007 Jun 5.
It has been suggested that the reinforcing properties of ethanol are in part mediated via an A2 activation of cAMP/PKA signaling in the nucleus accumbens, predicting that administration of an A2a antagonist might reduce ethanol reward and consumption. We therefore examined the effect of the adenosine A2a receptor antagonist 3,7-dimethylpropargylxanthine (DMPX, 3, and 10 mg/kg intraperitoneal) on alcohol reinforcement, anxiety-related, depression, and rewarding behaviors in nonselected Wistar rats.
Operant ethanol self-administration was used for examining alcohol intake, elevated plus-maze and Vogel conflict test for anxiety-related behavior, Porsolt swim test for depression-like behavior, and conditioned place preference for examination of the rewarding properties of the drug.
3,7-Dimethylpropargylxanthine decreased lever-pressing for ethanol in a dose-dependent manner. When analyzed as percentage of pretreatment baseline, maximum suppression was approximately 60% (39+/-7.5 vs 98+/-12%, mean+/-SEM, p=0.017). This effect was behaviorally specific, as no effect was found on the water lever. In agreement with previously published data, stimulation of locomotion was found (beam-breaks: 3590+/-540 vs 2475+/-240, 10 mg/kg vs saline, p=0.048). No anxiety-modulating effects were seen in either the elevated plus-maze or the Vogel conflict test. 3,7-Dimethylpropargylxanthine was not found to have intrinsic rewarding properties in the conditioned place preference model.
In summary, DMPX produced a robust and behaviorally selective reduction of ethanol reinforcement, while anxiety-modulating effects were less consistent. These results bring further support to a role for adenosine in the regulation of ethanol consumption and possibly alcohol addiction/abuse, and the A2a receptor as a potential target for the treatment of alcoholism and alcohol abuse.
有人提出,乙醇的强化特性部分是通过伏隔核中cAMP/PKA信号通路的A2激活介导的,这预测给予A2a拮抗剂可能会减少乙醇奖赏和消耗。因此,我们研究了腺苷A2a受体拮抗剂3,7-二甲基炔丙基黄嘌呤(DMPX,腹腔注射3和10mg/kg)对非选择Wistar大鼠的酒精强化、焦虑相关、抑郁和奖赏行为的影响。
采用操作性乙醇自我给药来检测酒精摄入量,采用高架十字迷宫和Vogel冲突试验检测焦虑相关行为,采用Porsolt游泳试验检测抑郁样行为,采用条件性位置偏爱试验检测药物的奖赏特性。
DMPX以剂量依赖性方式减少了对乙醇的杠杆按压。以预处理基线的百分比分析时,最大抑制约为60%(39±7.5对98±12%,平均值±标准误,p=0.017)。这种作用具有行为特异性,因为对水杠杆没有影响。与先前发表的数据一致,发现其具有运动刺激作用(光束中断次数:3590±540对2475±240,10mg/kg对生理盐水,p=0.048)。在高架十字迷宫或Vogel冲突试验中均未观察到焦虑调节作用。在条件性位置偏爱模型中未发现DMPX具有内在奖赏特性。
总之,DMPX对乙醇强化产生了强烈且行为选择性的降低,而焦虑调节作用不太一致。这些结果进一步支持了腺苷在乙醇消耗调节以及可能的酒精成瘾/滥用中的作用,以及A2a受体作为治疗酒精中毒和酒精滥用的潜在靶点。